{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe buffer can contain 10 mM Hepes.\n Passing the test antigen over the chip's capture surface at 1024 nM, 256 nM, 64 nM, 16 nM"}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "mM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "1024", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "256", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "64", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "16", "unit": "nM"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria, as none of the sentences contain a specific molecule name, ID, or other identifier, a bioactivity metric (IC50, Ki, Kd, EC50, etc.), a specific numeric value for that metric, and a unit for that value. The text primarily discusses methods, frequencies, and genotypes in general terms, without providing specific data on bioactivity metrics."}
{"raw_mentions": "In an example, specific binding means binding with an affinity (Kd) of 1 mM, 100 nM, 10 nM or 1 nM or less, eg, as determined by SPR."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": "1", "unit": "mM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": "100", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": "10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": "1", "unit": "nM"}]}
{"raw_mentions": "Specific binding can be characterized by an equilibrium dissociation constant of at least about 1\u00d710<sup>\u22126</sup>M or less (e.g., a smaller KD denotes a tighter binding)."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "1\u00d710\u22126", "unit": "M"}]}
{"raw_mentions": "There are no sentences in the provided text that meet the specified criteria, as the text appears to be a list of molecule names, IDs, and other identifiers without any associated bioactivity metrics or numeric values."}
{"raw_mentions": "The ligand, method, use, kit or composition of any one of clauses 1 to 12, wherein the ligand (eg, antibody or fragment) has been determined to specifically bind one or more human TOI variants as disclosed herein, for example, with a KD of 1 nM or less (eg, 100 or 10 pM or less) as determined by SPR."}
{"final_json": [{"molecule_name": "antibody or fragment", "protein_target_name": "human TOI variants", "binding_metric": "KD", "value": "1", "unit": "nM"}, {"molecule_name": "antibody or fragment", "protein_target_name": "human TOI variants", "binding_metric": "KD", "value": "100", "unit": "pM"}, {"molecule_name": "antibody or fragment", "protein_target_name": "human TOI variants", "binding_metric": "KD", "value": "10", "unit": "pM"}]}
{"raw_mentions": "The ligand, method, use, kit or composition of any one of clauses 1 to 89, wherein the ligand (eg, antibody or fragment) binds said human TOI with a dissociation constant (Kd) of 1 nM or less as determined by SPR, (eg, 100, 10 or 1 pM or less)."}
{"final_json": [{"molecule_name": "antibody or fragment", "protein_target_name": "human TOI", "binding_metric": "Kd", "value": "1", "unit": "nM"}, {"molecule_name": "antibody or fragment", "protein_target_name": "human TOI", "binding_metric": "Kd", "value": "100", "unit": "pM"}, {"molecule_name": "antibody or fragment", "protein_target_name": "human TOI", "binding_metric": "Kd", "value": "10", "unit": "pM"}, {"molecule_name": "antibody or fragment", "protein_target_name": "human TOI", "binding_metric": "Kd", "value": "1", "unit": "pM"}]}
{"raw_mentions": "None. \n\nThere are no sentences in the provided text that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric (IC50, Ki, Kd, EC50 and their variations), a specific numeric value for that metric, and a unit for that value."}
{"raw_mentions": "Specific binding can be characterized by an equilibrium dissociation constant of at least about 1\u00d710<sup>\u22126 </sup>M or less (e.g., a smaller KD denotes a tighter binding)."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "KD", "value": "1\u00d710\u22126", "unit": "M"}]}
{"raw_mentions": "In an example, the ligand binds (or has been determined as binding) to the PCSK9 with an affinity (Kd) of 1 mM, 100 nM, 10 nM or 1 nM or less. \nIn an embodiment, the affinity is no less than 10, 100 or 1000 fM."}
{"final_json": [{"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "1", "unit": "mM"}, {"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "100", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "10", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "1", "unit": "nM or less"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "affinity", "value": "no less than 10", "unit": "fM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "affinity", "value": "no less than 100", "unit": "fM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "affinity", "value": "no less than 1000", "unit": "fM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nFor example, the ligand specifically binds to mature form f and/or c as well as form a. Determination of such binding can be performed by any antibody binding test as known in the art, eg, by surface plasmon resonance. Binding to each such form is, for example, respectively with a Kd of at least 1 mM, 100 nM, 1 nM, 100 pM, 10 pM or 1 pM.\n\nIn an example, the ligand binds form a and a PCSK9 selected from the group consisting of forms f, c, r, p, m, e, h, aj and q, wherein the ligand binding to said selected form is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an example, the ligand binds form a and form f; wherein the ligand binding to form f is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an example, the ligand binds form a and form c, wherein the ligand binding to form c is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an example, the ligand binds form a and form r, wherein the ligand binding to form r is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an example, the ligand binds form a and form p, wherein the ligand binding to form p is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an example, the ligand binds form a and form m, wherein the ligand binding to form m is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an example, the ligand binds form a and form e, wherein the ligand binding to form e is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an example, the ligand binds form a and form h, wherein the ligand binding to form h is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an example, the ligand binds form a and form aj, wherein the ligand binding to form aj is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an example, the ligand binds form a and form q, wherein the ligand binding to form q is with a Kd (determined by SPR) that is at least 60, 70, 80, 90 or 95% of the Kd for binding to form a.\n\nIn an embodiment, the ligand has a Kd of less (binding more tightly) than 10^\u22127, 10^\u22128, 10^\u22129, 10^\u221210, 10^\u221211, 10^\u221212, 10^\u221213 M for binding to one, two or more of the rare variants disclosed herein and optionally also the a and/or a\u2032 form.\n\nIn an embodiment, the ligand has an IC50 for blocking the binding of LDLR to one or more of the rare PCSK9 variants disclosed herein (and optionally also the a and/or a\u2032 form) of less than 1 microM, 1000 nM to 100 nM, 100 nM to 10 nM, 10 nM to 1 nM, 1000 pM to 500 pM, 500 pM to 200 pM, less than 200 pM, 200 pM to 150 pM, 200 pM to 100 pM, 100 pM to 10 pM, 10 pM to 1 pM.\n\nIn an embodiment, the ligand has an IC50 for blocking the binding of LDLR to the a and/or a\u2032 form of PCSK9 that is no more than 1000, 100, 90, 80, 70, 60, 50, 40, 30, 20 or 10-fold more (ie, more inhibitory) than the IC50 for blocking the binding of LDLR to one or more of the rare PCSK9 variants disclosed herein (eg, one or more PCSK9 proteins comprising a sequence selected from SEQ ID NOs: 4 to 27)."}
{"final_json": [{"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "1 mM", "unit": "mM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "100 nM", "unit": "nM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "1 nM", "unit": "nM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "100 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "10 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "1 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form f", "binding_metric": "Kd", "value": "60%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form f", "binding_metric": "Kd", "value": "70%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form f", "binding_metric": "Kd", "value": "80%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form f", "binding_metric": "Kd", "value": "90%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form f", "binding_metric": "Kd", "value": "95%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form c", "binding_metric": "Kd", "value": "60%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form c", "binding_metric": "Kd", "value": "70%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form c", "binding_metric": "Kd", "value": "80%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form c", "binding_metric": "Kd", "value": "90%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form c", "binding_metric": "Kd", "value": "95%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form r", "binding_metric": "Kd", "value": "60%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form r", "binding_metric": "Kd", "value": "70%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form r", "binding_metric": "Kd", "value": "80%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form r", "binding_metric": "Kd", "value": "90%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form r", "binding_metric": "Kd", "value": "95%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form p", "binding_metric": "Kd", "value": "60%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form p", "binding_metric": "Kd", "value": "70%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form p", "binding_metric": "Kd", "value": "80%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form p", "binding_metric": "Kd", "value": "90%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form p", "binding_metric": "Kd", "value": "95%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form m", "binding_metric": "Kd", "value": "60%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form m", "binding_metric": "Kd", "value": "70%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form m", "binding_metric": "Kd", "value": "80%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form m", "binding_metric": "Kd", "value": "90%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form m", "binding_metric": "Kd", "value": "95%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form e", "binding_metric": "Kd", "value": "60%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form e", "binding_metric": "Kd", "value": "70%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form e", "binding_metric": "Kd", "value": "80%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form e", "binding_metric": "Kd", "value": "90%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form e", "binding_metric": "Kd", "value": "95%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form h", "binding_metric": "Kd", "value": "60%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form h", "binding_metric": "Kd", "value": "70%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form h", "binding_metric": "Kd", "value": "80%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form h", "binding_metric": "Kd", "value": "90%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form h", "binding_metric": "Kd", "value": "95%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form aj", "binding_metric": "Kd", "value": "60%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form aj", "binding_metric": "Kd", "value": "70%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form aj", "binding_metric": "Kd", "value": "80%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form aj", "binding_metric": "Kd", "value": "90%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form aj", "binding_metric": "Kd", "value": "95%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form q", "binding_metric": "Kd", "value": "60%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form q", "binding_metric": "Kd", "value": "70%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form q", "binding_metric": "Kd", "value": "80%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form q", "binding_metric": "Kd", "value": "90%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9 form q", "binding_metric": "Kd", "value": "95%", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "<10^\u22127 M", "unit": "M"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "<10^\u22128 M", "unit": "M"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "<10^\u22129 M", "unit": "M"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "<10^\u221210 M", "unit": "M"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "<10^\u221211 M", "unit": "M"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "<10^\u221212 M", "unit": "M"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "<10^\u221213 M", "unit": "M"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "<1 microM", "unit": "microM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "1000 nM to 100 nM", "unit": "nM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "100 nM to 10 nM", "unit": "nM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "10 nM to 1 nM", "unit": "nM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "1000 pM to 500 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "500 pM to 200 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "<200 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "200 pM to 150 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "200 pM to 100 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "100 pM to 10 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "10 pM to 1 pM", "unit": "pM"}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "1000-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "100-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "90-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "80-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "70-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "60-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "50-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "40-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "30-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "20-fold", "unit": null}, {"molecule_name": "ligand", "protein_target_name": "PCSK9", "binding_metric": "IC50", "value": "10-fold", "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n4. An antigen binding protein that selectively binds to PCSK9, wherein said antigen binding protein binds to PCSK9 with a Kd that is less than 100 pM.\n5. An antigen binding protein that binds to a PCSK9 protein of SEQ ID NO: 303 in a first manner, wherein the antigen binding protein binds to a variant of PCSK9 in a second manner, wherein said PCSK9 variant has at least one point mutation at a position selected from the group consisting of: 207, 208, 185, 181, 439, 513, 538, 539, 132, 351, 390, 413, 582, 162, 164, 167, 123, 129, 311, 313, 337, 519, 521, and 554 of SEQ ID NO: 303, wherein the first manner comprises a first EC50, a first Bmax, or a first EC50 and a first Bmax, wherein the second manner comprises a second EC50, a second Bmax, or a second EC50 and a second Bmax, and wherein a value for the first manner is different from a value for the second manner, and wherein the antigen binding protein comprises a light chain comprising an amino acid sequence of SEQ ID NO: 46, and wherein the antigen binding protein comprises a heavy chain comprising an amino acid sequence of SEQ ID NO: 60."}
{"final_json": [{"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "<100", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "EC50", "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn one embodiment, the antibody or antigen-binding fragment is characterized as exhibiting an enhanced binding affinity (KD) for hPCSK9 at pH 5.5 relative to the KD at pH 7.4, as measured by plasmon surface resonance. \nIn a specific embodiment, the antibody or fragment thereof exhibits at least a 20-fold, at least a 40-fold or at least a 50-fold enhanced affinity for PCSK9 at an acidic pH relative to a neutral pH, as measured by surface plasmon resonance."}
{"final_json": [{"molecule_name": "antibody or antigen-binding fragment", "protein_target_name": "hPCSK9", "binding_metric": "KD", "value": null, "unit": null}, {"molecule_name": "antibody or fragment thereof", "protein_target_name": "PCSK9", "binding_metric": null, "value": "20-fold, 40-fold or 50-fold", "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n3. The method of clause 1 or 2, wherein the specific binding to said PCSK9 is binding with a dissociation constant (Kd) of 1 nM or less, eg, 100, 10 or 1 pM or less."}
{"final_json": [{"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "100", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "10", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "1", "unit": "pM"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics (IC50, Ki, Kd, EC50), numeric values, and units. The text appears to describe methods, regimens, and ligands in general terms, without providing specific data or measurements."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n15. The method of any one of clauses 1 to 14, wherein the specific binding to said PCSK9 is binding with a dissociation constant (Kd) of 1 nM or less, eg, 100, 10 or 1 pM or less."}
{"final_json": [{"molecule_name": null, "protein_target_name": "PCSK9", "binding_metric": "Kd", "value": "1", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nVariant/Antibodyka (1/Ms)kd (1/s)KD (nM)PCSK9 a316P1.37E+062.75E\u2212040.20131H41.14E+066.38E\u2212050.056Evolocumab1.14E+052.62E\u2212050.229\nPCSK9 a\u2032316P1.50E+062.72E\u2212040.18131H41.23E+066.06E\u2212050.049Evolocumab1.24E+052.29E\u2212050.185\nPCSK9 c316P1.49E+062.75E\u2212040.18431H41.22E+065.69E\u2212050.047Evolocumab1.20E+052.20E\u2212050.183\nPCSK9 r316P1.40E+062.76E\u2212040.19731H41.15E+065.82E\u2212050.051Evolocumab1.16E+052.67E\u2212050.230\nPCSK9 f316P1.39E+062.82E\u2212040.20331H41.13E+065.95E\u2212050.053Evolocumab1.16E+052.66E\u2212050.229\nPCSK9 p316P1.39E+062.73E\u2212040.19631H41.14E+066.12E\u2212050.054Evolocumab1.14E+052.50E\u2212050.219"}
{"final_json": [{"molecule_name": "Evolocumab", "protein_target_name": "PCSK9", "binding_metric": "KD", "value": "1.37E+06", "unit": "nM"}, {"molecule_name": "Evolocumab", "protein_target_name": "PCSK9", "binding_metric": "KD", "value": "1.50E+06", "unit": "nM"}, {"molecule_name": "Evolocumab", "protein_target_name": "PCSK9", "binding_metric": "KD", "value": "1.49E+06", "unit": "nM"}, {"molecule_name": "Evolocumab", "protein_target_name": "PCSK9", "binding_metric": "KD", "value": "1.40E+06", "unit": "nM"}, {"molecule_name": "Evolocumab", "protein_target_name": "PCSK9", "binding_metric": "KD", "value": "1.39E+06", "unit": "nM"}, {"molecule_name": "Evolocumab", "protein_target_name": "PCSK9", "binding_metric": "KD", "value": "1.39E+06", "unit": "nM"}]}
